Effect of L-N6-(1-iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide

Journal of Periodontal Research

Volumn 42, Issue 2, 2007, Pages 124-130

  Sosroseno, Wilhas ^a,b,e   Musa, M ^b   Ravichandran, M ^b   Ibrahim, M Fikri ^a   Bird, P S ^c   Seymour, G J ^c,d  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Actinobacillus actinomycetemcomitans; L N6 (1 iminoethyl) lysine; Lipopolysaccharide; Murine

Indexed keywords

BACTERIUM ANTIBODY; DRUG DERIVATIVE; ENZYME INHIBITOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; LYSINE; N(6) (1 IMINOETHYL)LYSINE; N(6)-(1-IMINOETHYL)LYSINE; NITRIC OXIDE; NOS2 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ABSCESS; ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BACTERIAL INFECTION; BAGG ALBINO MOUSE; BLOOD; DRUG ANTAGONISM; FEMALE; IMMUNOLOGY; METABOLISM; MOUSE; PASSIVE IMMUNIZATION; SPLEEN; TH1 CELL;

ABSCESS; ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, BACTERIAL; ENZYME INHIBITORS; FEMALE; IMMUNIZATION, PASSIVE; INTERFERON TYPE II; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LYSINE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SPLEEN; TH1 CELLS;

EID: 33847027973     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00925.x     Document Type: Article

References (41)

1. Mungrue IN, Bredt DS, Stewart DJ, Husain M. From molecules to mammals: what's NOS got to do with it?. Acta Physiol Scand 2003;179:123- 135.
2. Kröncke K-D, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998;113:147-156.
3. Ehlers S, Kutsch S, Benini J et al. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 1999;98:313-323.
4. 6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. Eur J Pharmacol 1995;294:703-712.
5. Reilly CM, Farrelly LW, Viti D et al. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int 2002;61:839-846.
6. Sosroseno W, Herminajeng E. The immunopathology of chronic inflammatory periodontal disease. FEMS Immunol Med Microbiol 1995;10:171-180.
7. Gemmell, E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. CRC Crit Rev Oral Biol 2002;13:17-34.
8. Kendall HK, Haase HR, Li H, Xiao Y, Bartold PM. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodont Res 2000;35:194-200.
9. Lappin DF, Kjeldsen M, Sander L, Kinane DF. Inducible nitric oxide synthase expression in periodontitis. J Periodont Res 2000;35:369-373.
10. Hirose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K. Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol 2001;72:590-597.
11. Gaspirc B, Masera A, Skaleric U. Immunolocalization of inducible nitric oxide synthase in localized juvenile periodontitis patients. Connect Tissue Res 2002;43:413-418.
12. Batista AC, Silva TA, Chun JH, Lara VS. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis 2002;8:254-260.
13. Güllü C, Ozmeric N, Tokman B, Elgün S, Balos K. Effectiveness of scalling and root planning versus modified Widman flap on nitric oxide synthase and arginase activity in patients with chronic periodontitis. J Periodont Res 2005;40:168-175.
14. Daghigh F, Borghaei RC, Thornton RD, Bee JH. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol 2002;73:392-400.
15. Gyurko R, Boustany G, Huang PL et al. Mice lacking inducible nitric oxide synthase demonstrating impaired killing of Porphyromonas gingivalis. Infect Immun 2003;71:4917-4924.
16. Gyurko R, Shoji H, Battaglino RA et al. Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss. Bone 2005;36:472-479.
17. Lohinai Z, Benedek P, Feher E et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123:353-360.
18. Herminajeng E, Asmara W, Yuswanto A, Barid I, Sosroseno W. Protective humoral immunity induced by surface-associated material from Actinobacillus actinomycetemcomitans in mice. Microbes Infect 2001;3:997- 1003.
19. Sosroseno W, Herminajeng E. The role of macrophages in the induction of murine immune response to Actinobacillus actinomycetemcomitans. J Med Microbiol 2002;51:581-588.
20. Yamashita K, Eastcott JW, Taubman MA, Smith DJ, Cox DS. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect Immun 1991;59:1529- 1534.
21. Harada Y, Han X, Yamashita K et al. Effect of adoptive transfer of antigen-specific B cells on periodontal bone resorption. J Periodont Res 2006;41:101-107.
22. Wilson M, Henderson B. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol Rev 1995;17:365-379.
23. Blix IJS, Helgeland K. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774. Eur J Oral Sci 1998;106:576-581.
24. Sosroseno W, Herminajeng E, Budiarti S, Susilowati H. Nitric oxide production by murine spleen cells stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Anaerobe 2002;8:333-339.
25. Sosroseno W, Barid I, Herminajeng E, Susilowati H. Nitric oxide production by a murine macrophage cell line (RAW264.7) induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002;17:72-78.
26. Lyall F, Young A, Green IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995;173:714-718.
27. Sosroseno W, Bird PS, Gemmell E, Seymour GJ. Induction of suppressor cells following mucosal presentation of Actinomyces viscosus in mice. Oral Microbiol Immunol 2003;18:318-322.
28. Babu BR, Griffith OW. Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol 1998;2:491-500.
29. Zhang C, Walker LM, Hinson JA, Mayeux PR. Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition. J Pharmacol Exp Ther 2000;293:968-293.
30. Cockrell A, Laroux FS, Jourd'heuil D et al. Role of inducible nitric oxide synthase in leukocyte extravasation in vivo. Biochem Biophys Res Commun 1999;257:684-686.
31. Lortie MJ, Ishizuka S, Schwartz D, Blantz RC. Bioactive products of arginine in sepsis: tissue and plasma composition after LPS and iNOS blockage. Am J Physiol Cell Physiol 2000;278:C1191-C1199.
32. Kato T, Honma K, Yamanaka A, Miura T, Okuda K. Heterogeneity in the immune response to serotype b LPS of Actinobacillus actinomycetemcomitans in inbred strains of mice. FEMS Med Microbiol Immunol 2000;28:67-70.
33. Gabbai FB, Boggiano C, Peter T et al. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997;159:6266-6275.
34. Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987;236:944- 947.
35. McKay DM, Lu J, Jedrzkiewicz S, Ho W, Sharkey KA. Nitric oxide participates in the the recovery of normal jejunal epithelial ion transport following exposure to the superantigen, Staphylococcus aureus enterotoxin B. J Immunol 1999;45:19-4526.
36. Herminajeng E, Sosroseno W, Bird PS, Seymour GJ. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model. J Periodontol 2001;72:1527-1534.
37. Rochim A, Herminajeng E, Sosroseno W. The effects of exogenous interleukin-12 on the induction of immune response to Porphyromonas gingivalis in vivo in mice. Asian Pac J Allergy Immunol 2001;19:59-62.
38. Tanaka S, Fakher M, Barbour SE, Schenkein HA, Tew JG. Influence of proinflammatory cytokines on Actinobacillus actinomycetemcomitans specific IgG responses. J Periodont Res 2006;41:1-9.
39. Veilhelmann A, Hofbauer A, Krombach F, Dirger M, Maier M, Refior HJ, Messmer K. Differential function of nitric
40. oxide in murine antigen-induced arthritis. Rheumatology 2002;41:509-517.
41. Gemmell E, Bird PS, Ford PJ et al. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. Oral Microbiol Immunol 2004;19:247-251.